Pharmaceuticals

Chiesi, Maria Paola as president: first woman at the top of the group

Planned change in the governance of the Parma-based group: Alessandro Chiesi leaves the presidency and assumes the role of vice-president

by Alessandro Cicognani

La neopresidente del gruppo Chiesi, Maria Paola Chiesi

2' min read

Translated by AI
Versione italiana

2' min read

Translated by AI
Versione italiana

Chiesi entrusts Maria Paola Chiesi with the presidency of the Board of Directors and opens a new phase in the governance of the Parma-based biopharmaceutical group. The appointment, announced today and effective immediately, marks a significant step also on a symbolic level: Maria Paola Chiesi is the first woman to hold this position in the company's history.

The transition was planned and is part of the path of family continuity and intergenerational responsibility that characterises the group. Maria Paola Chiesi succeeds her cousin Alessandro Chiesi, who ends his term after almost three years as President and will continue to be part of the governance as Vice-President.

Loading...

During his tenure, Alessandro Chiesi led the company through a period of international development and strengthened governance. "It has been a privilege for me to serve as chairman during a period of evolution for the company," said Alessandro Chiesi. "What has remained unchanged are the group's solid roots in our distinctive values, strong sense of responsibility and long-term vision. I congratulate Maria Paola on her appointment and offer her our full support."

The new chairwoman, a member of the family and of the Board of Directors, has contributed over the past thirty years, including through operational roles, to the group's strategic planning and the integration of sustainability into decision-making processes. Her appointment, unanimously approved by the Board, aims to strengthen this very axis: sustainability as a stable pillar of industrial strategy, an integral part of the business model and long-term value creation.

"I take on this new position with a deep sense of responsibility and with the aim of strengthening the continuity and commitment to the values that have guided the Group for generations," said Maria Paola Chiesi. "For us, 'science that cures' means pursuing scientific innovation with responsibility for its impact on people, society and the environment."

Headquartered in Parma and with 90 years of history, Chiesi closed 2025 with over €3.6 billion in revenues, up 8.2% on the previous year. Certified B Corp from 2019, it has 31 sales subsidiaries worldwide and aims to achieve zero net greenhouse gas emissions by 2035.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti